Horizon Therapeutics Public Limited Company

(HZNP) Trade

By |

Profile

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the primary care segment. It markets medicines in the areas of orphan diseases, rheumatology and primary care. The majority of revenue is generated in the United States.

Contact Information

Website: www.horizonpharma.com
Email: investor-relations@horizonpharma.com
Main Phone: +353 17722100
Address: 1 Burlington Road
Address 2: Connaught House, 1st Floor
City / Town: Dublin 4
Country: IRL
Postal Code: D04 C5Y6

Issuer Information

Exchange: NGS
CEO: Timothy P. Walbert
Employees: 1175
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the primary care segment. It markets medicines in the areas of orphan diseases, rheumatology and primary care. The majority of revenue is generated in the United States.

Contact Information

Website: www.horizonpharma.com
Email: investor-relations@horizonpharma.com
Main Phone: +353 17722100
Address: 1 Burlington Road
Address 2: Connaught House, 1st Floor
City / Town: Dublin 4
Country: IRL
Postal Code: D04 C5Y6

Issuer Information

Exchange: NGS
CEO: Timothy P. Walbert
Employees: 1175
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 36.36 $ 0.33 (0.92%)
Last Price 36.36 Change $ 0.33 Change % 0.92 Tick N/A
Bid 36.36 Bid Size 100.00 Ask 38.00 Ask Size 100.00
Open 36.21 High 36.54 Low 36.00 Prev Close 36.03
Last Trade Volume 742,507 52 Wk Hi 39.10 52 Wk Low 20.05
Market Cap 6.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 187,302,229.00 EPS (TTM) 0.26 PE Ratio 138.60 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 36 64
Number of Buys 18 32
Number of Sells 18 32
Net Activity 242822 343770
Last 10 Buys Shares
Michael G. Grey 1,000
H. Thomas Watkins 1,000
H. Thomas Watkins 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Jeffrey W. Bird 1,000
Last 10 Sell Shares
Brian K. Beeler 1,000
Brian K. Beeler 1,000
Timothy P. Walbert 1,000
Brian K. Beeler 1,000
Robert F. Carey 1,000
Robert F. Carey 1,000
Jeffrey W. Sherman 1,000
Virinder Nohria 1,000
Jeffrey W. Sherman 1,000
Jeffrey W. Sherman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 20 20 20 20
Standard Deviation 3.21 3.21 3.21 3.21
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1.29 1.29